ClearNote Health is a privately held company dedicated to improving early detection and monitoring for some of the deadliest forms of cancer. Developed by scientists in the Stephen Quake laboratory at Stanford University, the company's patented Virtuoso epigenomics platform builds on the latest advances in artificial intelligence and bioinformatics to measure active biological differences between cancer and healthy cells in a blood sample.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
05/28/26	$52,000,000	Series D	Dr. Stephen Quake Mattias Westman Sandy Weill	undisclosed